Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip G Conaghan

Showing results (151-160 of 503) with videos related to

Pageof 51
Sort By:
Rheumatology International|November 18, 2017
A systematic review assessing non-pharmacological conservative treatment studies for people with non-inflammatory multi-joint pain: clinical outcomes and research design considerationsC Comer, T O Smith, B Drew, et al.
Arthritis and Rheumatism|July 19, 2002
Can very high-dose anti-tumor necrosis factor blockade at onset of rheumatoid arthritis produce long-term remission?Philip G Conaghan, Mark A Quinn, Philip O'Connor, et al.
The Journal of Rheumatology|November 3, 2016
Knee Pain Predicts Subsequent Shoulder Pain and the Association Is Mediated by Leg Weakness: Longitudinal Observational Data from the Osteoarthritis InitiativeLaura L Laslett, Petr Otahal, Elizabeth M A Hensor, et al.
Clinical and Experimental Rheumatology|November 19, 2021
Flexion contracture is associated with knee joint degeneration on magnetic resonance imaging: data from the Osteoarthritis InitiativeT Mark Campbell, Guy Trudel, Philip G Conaghan, et al.
Advances in Therapy|July 7, 2019
Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled TrialHarris A Ahmad, Joshua F Baker, Mikkel Østergaard, et al.
The Journal of Rheumatology|March 7, 2008
Using extremity magnetic resonance imaging to assess and monitor early rheumatoid arthritis: the optimal joint combination to be scanned in clinical practiceEwa Olech, Jane E Freeston, Philip G Conaghan, et al.
Annals of the Rheumatic Diseases|May 15, 2020
Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA studyPaul Emery, Gerd R Burmester, Esperanza Naredo, et al.
Rheumatology International|December 5, 2019
Investigating the patient acceptable symptom state cut-offs: longitudinal data from a community cohort using the shoulder pain and disability indexGui Tran, Bright Dube, Sarah R Kingsbury, et al.
Annals of the Rheumatic Diseases|July 10, 2007
A modification of the Omeract RA MRI score for erosions for use with an extremity MRI system with reduced field of viewJane E Freeston, Ewa Olech, David Yocum, et al.
RMD Open|December 10, 2021
Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decadesSamantha S R Crossfield, Helena Marzo-Ortega, Sarah R Kingsbury, et al.
Pageof 51

Showing results (151-160 of 503) with videos related to

Sort By:
Pageof 51
Rheumatology International|November 18, 2017
A systematic review assessing non-pharmacological conservative treatment studies for people with non-inflammatory multi-joint pain: clinical outcomes and research design considerationsC Comer, T O Smith, B Drew, et al.
Arthritis and Rheumatism|July 19, 2002
Can very high-dose anti-tumor necrosis factor blockade at onset of rheumatoid arthritis produce long-term remission?Philip G Conaghan, Mark A Quinn, Philip O'Connor, et al.
The Journal of Rheumatology|November 3, 2016
Knee Pain Predicts Subsequent Shoulder Pain and the Association Is Mediated by Leg Weakness: Longitudinal Observational Data from the Osteoarthritis InitiativeLaura L Laslett, Petr Otahal, Elizabeth M A Hensor, et al.
Clinical and Experimental Rheumatology|November 19, 2021
Flexion contracture is associated with knee joint degeneration on magnetic resonance imaging: data from the Osteoarthritis InitiativeT Mark Campbell, Guy Trudel, Philip G Conaghan, et al.
Advances in Therapy|July 7, 2019
Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled TrialHarris A Ahmad, Joshua F Baker, Mikkel Østergaard, et al.
The Journal of Rheumatology|March 7, 2008
Using extremity magnetic resonance imaging to assess and monitor early rheumatoid arthritis: the optimal joint combination to be scanned in clinical practiceEwa Olech, Jane E Freeston, Philip G Conaghan, et al.
Annals of the Rheumatic Diseases|May 15, 2020
Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA studyPaul Emery, Gerd R Burmester, Esperanza Naredo, et al.
Rheumatology International|December 5, 2019
Investigating the patient acceptable symptom state cut-offs: longitudinal data from a community cohort using the shoulder pain and disability indexGui Tran, Bright Dube, Sarah R Kingsbury, et al.
Annals of the Rheumatic Diseases|July 10, 2007
A modification of the Omeract RA MRI score for erosions for use with an extremity MRI system with reduced field of viewJane E Freeston, Ewa Olech, David Yocum, et al.
RMD Open|December 10, 2021
Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decadesSamantha S R Crossfield, Helena Marzo-Ortega, Sarah R Kingsbury, et al.
Pageof 51